[Venoruton and capillary permeability].
A new system to evaluate capillary permeability, the vacuum suction chamber (VSC) device, was used to assess the effects of Venoruton in patients with venous hypertension. A temporary, superficial skin lesion (wheal) was produced with the VSC device by negative pressure (30 mmHg) applied for 10 minutes on the internal, perimalleolar region. Wheals disappear in less than 60 minutes in normals while in patients with venous hypertension the wheal is more persistent, requiring a significantly longer time to disappear. This new technique was used in association with laser-Doppler flowmetry to evaluate the efficacy of Venoruton (1000 mgs t.i.d.) administered for 2 weeks on venous hypertension. Results indicate a positive effect of Venoruton in reducing the abnormally increased capillary permeability in venous hypertension and are proportional to the changes observed in signs and symptoms after treatment.
M R
MR
Cesarone
G
G
Laurora
M
M
Gabini
B M
BM
Errichi
C
C
Candiani
G
G
Belcaro
D000328:Adult; D002199:Capillary Permeability / Q000187:drug effects*; D005260:Female; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D012431:Rutin / Q000031:analogs & derivatives*; D012882:Skin Tests / Q000379:methods; D014690:Venous Pressure / Q000187:drug effects*
D006896:Hydroxyethylrutoside; D012431:Rutin; C005865:troxerutin
Venoruton e permeabilità capillare.